Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dana-Farber Cancer Institute
MedTech
Dana-Farber AI traces unknown cancers back to the source: study
Even with a standard diagnostic work-up, clinicians are still unable to find the original source of a tumor in about 3% to 5% of patients.
Conor Hale
Aug 7, 2023 11:35am
Roivant founder departs for White House bid—Chutes & Ladders
Feb 24, 2023 9:30am
Sanofi-backed biotech hauls in $70M series A for covalent bonds
Oct 14, 2022 6:30am
VBL lays off 35% of staff after failure-induced stock shock
Aug 2, 2022 11:03am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
Novel cancer vaccines look beyond T cells to better fight tumors
May 27, 2022 2:00pm
